This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jun;21(6):e293.

doi: 10.1016/S1470-2045(20)30170-4.

Effectiveness of anti-PD-1 for hepatocellular carcinoma

Rui Liao¹

Affiliations

Affiliation

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: liaorui99@163.com.

PMID: 32502446
DOI: 10.1016/S1470-2045(20)30170-4

Comment

Effectiveness of anti-PD-1 for hepatocellular carcinoma

Rui Liao. Lancet Oncol. 2020 Jun.

. 2020 Jun;21(6):e293.

doi: 10.1016/S1470-2045(20)30170-4.

Author

Rui Liao¹

Affiliation

¹ Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: liaorui99@163.com.

PMID: 32502446
DOI: 10.1016/S1470-2045(20)30170-4

No abstract available

PubMed Disclaimer

Comment in

Effectiveness of anti-PD-1 for hepatocellular carcinoma - Authors' reply.
Qin S, Ren Z, Meng Z, Chen Z, Chai X. Qin S, et al. Lancet Oncol. 2020 Jun;21(6):e294. doi: 10.1016/S1470-2045(20)30285-0. Lancet Oncol. 2020. PMID: 32502447 No abstract available.

Comment on

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial.
Qin S, Ren Z, Meng Z, Chen Z, Chai X, Xiong J, Bai Y, Yang L, Zhu H, Fang W, Lin X, Chen X, Li E, Wang L, Chen C, Zou J. Qin S, et al. Lancet Oncol. 2020 Apr;21(4):571-580. doi: 10.1016/S1470-2045(20)30011-5. Epub 2020 Feb 26. Lancet Oncol. 2020. PMID: 32112738 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information